View in EDS

101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic

Saved in:
Bibliographic Details
Title: 101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
Authors: Gomes, Fabio1 (AUTHOR), Gilding, Niall2 (AUTHOR), Tan, Vivian2 (AUTHOR), Christoforou, Katerina2 (AUTHOR), Rule, Joanne2 (AUTHOR), Aziez, Amine3 (AUTHOR), Januszewski, Adam4 (AUTHOR), Minchom, Anna5 (AUTHOR)
Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 176647750
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gomes%2C+Fabio%22">Gomes, Fabio</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gilding%2C+Niall%22">Gilding, Niall</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tan%2C+Vivian%22">Tan, Vivian</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Christoforou%2C+Katerina%22">Christoforou, Katerina</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rule%2C+Joanne%22">Rule, Joanne</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aziez%2C+Amine%22">Aziez, Amine</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Januszewski%2C+Adam%22">Januszewski, Adam</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Minchom%2C+Anna%22">Minchom, Anna</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lung+Cancer+%2801695002%29%22">Lung Cancer (01695002)</searchLink>. 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=176647750
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2024.107662
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gomes, Fabio
      – PersonEntity:
          Name:
            NameFull: Gilding, Niall
      – PersonEntity:
          Name:
            NameFull: Tan, Vivian
      – PersonEntity:
          Name:
            NameFull: Christoforou, Katerina
      – PersonEntity:
          Name:
            NameFull: Rule, Joanne
      – PersonEntity:
          Name:
            NameFull: Aziez, Amine
      – PersonEntity:
          Name:
            NameFull: Januszewski, Adam
      – PersonEntity:
          Name:
            NameFull: Minchom, Anna
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2024 Supplement 1
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 01695002
          Numbering:
            – Type: volume
              Value: 190
          Titles:
            – TitleFull: Lung Cancer (01695002)
              Type: main
ResultId 1